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thought to drive tumor cell migration.
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The existence of extracellular phosphoproteins has
been acknowledged for over a century. However,
research in this area has been undeveloped largely
because the kinases that phosphorylate secreted
proteins have escaped identification. Fam20C is a
kinase that phosphorylates S-x-E/pS motifs on pro-
teins in milk and in the extracellular matrix of bones
and teeth. Here, we show that Fam20C generates
the majority of the extracellular phosphoproteome.
Using CRISPR/Cas9 genome editing, mass spec-
trometry, and biochemistry, we identify more than
100 secreted phosphoproteins as genuine Fam20C
substrates. Further, we show that Fam20C exhibits
broader substrate specificity than previously appre-
ciated. Functional annotations of Fam20C substrates
suggest roles for the kinase beyond biomineraliza-
tion, including lipid homeostasis, wound healing,
and cell migration and adhesion. Our results estab-
lish Fam20C as the major secretory pathway protein
kinase and serve as a foundation for new areas of
investigation into the role of secreted protein phos-
phorylation in human biology and disease.
INTRODUCTION
Extracellular protein phosphorylation dates back to 1883, when
the secreted protein casein was shown to contain phosphate(Hammarsten, 1883). More than a century later, Manning et al.
(2002) assembled an evolutionary tree depicting over 500 human
protein kinases that phosphorylate a diverse array of substrates.
However, evidence is lacking that any of these kinases localize
within the secretory pathway where they could encounter pro-
teins destined for secretion. We recently identified a small family
of kinases that phosphorylate secreted proteins and proteogly-
cans (Figure 1A) (Tagliabracci et al., 2012). These enzymes
bear little sequence similarity to canonical protein kinases;
nevertheless, some of them are endowed with protein and sugar
kinase activities. (Ishikawa et al., 2008; Koike et al., 2009; Ta-
gliabracci et al., 2012, 2013a). We demonstrated that one of
these kinases, Fam20C, is the bona fide ‘‘Golgi casein kinase,’’
an enzyme that escaped identification for many years (Tagliab-
racci et al., 2012). Fam20C phosphorylates secreted proteins
within S-x-E/pSmotifs, including casein, fibroblast growth factor
23 (FGF23), and members of the small integrin-binding ligand,
N-linked glycoprotein (SIBLING) family (Ishikawa et al., 2012;
Lindberg et al., 2015; Tagliabracci et al., 2012, 2014). The crystal
structure of the Fam20C ortholog from Caenorhabditis elegans
displayed an atypical kinase-like fold and revealed several
unique features, such as disulfide bridges, N-linked glycosyla-
tions, and a novel insertion domain that is conserved in all
Fam20 family members (Xiao et al., 2013).
The members of this family of secretory pathway kinases can
phosphorylate both proteins and carbohydrates. In Drosophila,
four-jointed regulates planar cell polarity by phosphorylating
cadherin domains of Fat and Dachsous (Ishikawa et al., 2008).
Although the substrates for Fam20A, Fam198A, and Fam198B
are unknown, Fam20B phosphorylates a xylose residue within
the tetrasaccharide linkage region of proteoglycans (KoikeCell 161, 1619–1632, June 18, 2015 ª2015 Elsevier Inc. 1619
Figure 1. The Fam20C- and VLK-Related Secretory Pathway
Kinases
(A and B) Phylogenetic trees built with MOLPHY using distances (-J option)
calculated from an alignment of representative human proteins depicting (A)
the Fam20C-related kinases and (B) the VLK-related kinases (Fjx1, four-jointed
box 1; DIA1, Deleted in Autism 1; DIA1R, DIA1-related).
See also Figure S1.et al., 2009). This phosphorylation markedly stimulates the activ-
ity of galactosyltransferase II to promote proteoglycan biosyn-
thesis (Wen et al., 2014).
Moreover, a distantly related protein, Sgk196, originally
annotated as a pseudokinase, was recently shown to localize
in the ER/Golgi lumen and phosphorylate a mannose residue
on a-dystroglycan (Yoshida-Moriguchi et al., 2013). The
inability to carry out this phosphorylation due to loss-of-func-
tion mutations in the human SGK196 gene results in a congen-
ital form of muscular dystrophy (Jae et al., 2013; von Renesse
et al., 2014).
In addition to the aforementioned kinases, the vertebrate
lonesome kinase (VLK) is a secreted kinase that phosphorylates
extracellular proteins on tyrosine residues (Bordoli et al., 2014).
Interestingly, several proteins related to VLK also localize in
the secretory pathway and are predicted to have a kinase-
like fold (Figures 1B and S1) (Dudkiewicz et al., 2013). These
proteins are poorly characterized molecularly; however, several
of them have been genetically linked to neurological disorders,
including Deleted in Autism-1 (DIA1) and DIA1-Related (DIA1R)
(Aziz et al., 2011a, 2011b; Morrow et al., 2008; Tennant-Eyles
et al., 2011).
Phosphoproteomic studies have revealed that more than
two-thirds of human serum (Zhou et al., 2009), plasma (Carra-
scal et al., 2010) and cerebrospinal fluid (CSF) (Bahl et al.,
2008) phosphoproteins contain phosphate within a S-x-E/pS
motif (Table S1). These observations suggest that kinases in
the secretory pathway may have overlapping substrate speci-
ficity. Here, we provide evidence that Fam20C is responsible
for phosphorylating the vast majority of secreted phosphopro-
teins. We identify more than 100 secreted phosphoproteins as
genuine Fam20C substrates and uncover Fam20C-dependent
phosphorylation sites within or surrounding residues that are
mutated in human diseases (i.e., PCSK9, BMP4). Functional
annotations of Fam20C substrates suggest roles for the kinase
in a broad range of biological processes, including lipid ho-
meostasis, endopeptidase inhibitor activity, wound healing,
cell adhesion, and cell migration. Furthermore, we demon-
strate that depletion of Fam20C in breast cancer cells has a1620 Cell 161, 1619–1632, June 18, 2015 ª2015 Elsevier Inc.dramatic effect on cell adhesion, migration, and invasion. We
anticipate that this work will open new areas of research on
extracellular protein phosphorylation in human biology and
disease.
RESULTS
Fam20C Is Unique among All Known Secretory Pathway
Kinases
Many secretory pathway proteins undergo posttranslational
modifications within the lumen of the ER and Golgi apparatus.
N-terminal sequencing analysis of Fam20C purified from the
conditioned medium of HEK293T cells revealed the mature pro-
tein to be truncated by 92 residues (Figure 2A). Mutation of a
three amino acid stretch that spans this region (91LQD93 to
91AAA93) did not affect Fam20C secretion or activity as judged
by its ability to induce amobility change in the Fam20C substrate
osteopontin (OPN) (Figure 2B). Human Fam20C is N-linked gly-
cosylated on three Asn residues (N101, N335, and N470), and
glycosylation appears to be important for proper folding of the
enzyme because mutating these residues to Ala had a dramatic
effect on Fam20C secretion (Figure 2C). Moreover, mutation of
all three sites had a profound effect on Fam20C activity.
To determine if Fam20C is itself a phosphoprotein, we ex-
pressed Flag-tagged Fam20C in 32P orthophosphate-labeled
U2OS cells. Examination of Flag-immunoprecipitates from
conditioned medium revealed that wild-type (WT) Fam20C, but
not the catalytically inactive D478A mutant, incorporated 32P
(Figure 2D). These results suggest that Fam20C undergoes auto-
phosphorylation. There are three Fam20C consensus S-x-E
motifs within the kinase; however, individual mutation of each
Ser to Ala did not affect Fam20C activity and had modest effects
on Fam20C secretion (Figure 2E).
Studies using peptide substrates derived from known
secreted phosphoproteins have suggested that Fam20C phos-
phorylates Ser residues within a S-x-E/pS motif (Ishikawa
et al., 2012; Lasa-Benito et al., 1996; Meggio et al., 1989; Ta-
gliabracci et al., 2012). To determine Fam20C specificity in an
unbiased manner, we screened an arrayed combinatorial pep-
tide library consisting of 198 biotinylated substrates (Hutti
et al., 2004). Fam20C strongly selected Glu at the +2 position,
but displayed only minor selectivity at other positions (Figures
2F and 2G). This extraordinarily specific pattern of selectivity at
the +2 position is unique among all kinases previously profiled
(Mok et al., 2010).
To test whether other secretory kinases could phosphorylate
S-x-E/pS motifs, we expressed and purified each of the
Fam20C- and VLK-related proteins, as well as Sgk196, fused
to maltose binding protein (MBP) using an insect cell expression
system (Figure 2H). We then performed in vitro kinase assays
with recombinant OPN and a synthetic peptide representing an
S-x-E phosphorylation site in bovine b-casein (b28-40) as sub-
strates (Figures 2I and 2J). Fam20C displayed a robust ability
to phosphorylate OPN and b28-40, whereas the other secretory
pathway kinases did not, even though several of these proteins
were active enzymes based on their ability to autophosphory-
late. We conclude that Fam20C specificity is unique among the
known secretory pathway kinases.
Figure 2. Fam20C Activity Is Unique among the Known Secretory Pathway Kinases
(A) Schematic representation of human Fam20C depicting the signal peptide (SP; red), the putative pro-region (green), the kinase domain (tan), and the insertion
domain (pink). The mature, C-terminally tagged Fam20C purified from conditioned medium of HEK293T cells is truncated by 92 amino acids as determined by
Edman degradation. The amino acid sequence surrounding this region is shown. The N-linked glycosylation sites and the ‘‘DFG’’ metal binding residue, D478, are
also depicted.
(B) Protein immunoblotting of V5 and Flag immunoprecipitates from conditioned medium (CM) of U2OS cells co-expressing V5-tagged OPN (OPN:V5) with either
WT Fam20C (20C:Flag), 91LQD93-91AAA93 Fam20C (20CLQD-AAA:Flag), or Fam20C lacking the signal peptide (DSP20C:Flag). Extracts were analyzed for
Fam20C-Flag (or mutants) and GAPDH.
(legend continued on next page)
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Fam20C Generates the Majority of Secreted
Phosphoproteome
We engineered a C-terminal KDEL sequence on Fam20C to
prevent secretion of the kinase. When expressed in U2OS cells,
Fam20C containing a C-terminal KDEL sequence was not
secreted, yet could still phosphorylate secreted OPN (Figures
2K and S2). Thus, it appears that phosphorylation of Fam20C
substrates takes place in the lumen of the secretory pathway
in cells where both the kinase and substrate are produced.
These results also suggest that ATP is transported into the lumen
of the secretory pathway; however, themechanism bywhich this
occurs in unknown. Because many serum and plasma phospho-
proteins are synthesized and secreted from hepatocytes, we
performed subcellular fractionation experiments on rat liver
and detected endogenous Fam20C in the lumen of highly
enriched Golgi fractions (Figures S3A and S3B). Therefore, we
utilized the liver cell line HepG2 as a model system to ascertain
the relative contribution of Fam20C kinase activity to the
secreted phosphoproteome. We generated Fam20C knockout
(KO) HepG2 cells by means of CRISPR/Cas9 genome-editing
(Figures S3C–S3E) (Cong et al., 2013; Mali et al., 2013). Using
these cells, we performed a quantitative analysis of the
Fam20C-dependent secreted phosphoproteome (Figure 3A).
We collected serum-free conditioned medium from WT and
Fam20C KO cells, trypsinized the proteins, and labeled them
with isobaric tags (6-plex TMT). After combining the samples,
phosphopeptides were enriched, fractionated, and analyzed
by LC-MS/MS (Figure S4; Data S1). We restricted our analyses
to phosphoproteins that are secreted via the conventional secre-
tory pathway (i.e., signal peptide or luminal/extracellular domain
of transmembrane proteins) and identified 150 phosphopepti-
des representingmore than 50 distinct phosphoproteins (Figures
3B and 3C; Table 1). Remarkably, Fam20C KO cells displayed
a >2-fold reduction in90% of the significantly quantified phos-(C) Protein immunoblotting of V5 and Flag immunoprecipitates from CM of U
(20C:Flag), catalytically inactive D478A (20CD478A:Flag), or various N-linked gly
GAPDH. **Denotes that 20C:Flag immunoprecipitates were treated with PNGase
(D) Protein immunoblotting and autoradiography of Flag-immunoprecipitates fr
(20C:Flag) or catalytically inactive D478A (20C D478A:Flag).
(E) Protein immunoblotting of V5 and Flag immunoprecipitates from CM of U
(20C:Flag) or potential S-x-E phosphosite Flag-tagged mutants (S41A, S106A an
**Denotes that 20C:Flag and OPN:V5 immunoprecipitates were treated with l-ph
(F) Characterization of a consensus Fam20C phosphorylation motif by phospho
incorporation of 32P into a mixture of biotinylated peptides bound to a strepta
phospho-acceptors.
(G) Position-specific scoring matrix (PSSM) resulting from quantification of the in
(H) SDS-PAGE and Coomassie staining of MBP-tagged members of the Fam20
insect cells. (The tags for Fjx1 and Fam20B were cleaved with TEV).
(I) The Fam20C- and VLK-related kinases and Sgk196 were incubated with OPN
PAGE and autoradiography.
(J) The Fam20C- and VLK-related kinases and Sgk196 were incubated with b28-
scintillation counting. Note that Fam198Bwas not included in these reactions beca
mammalian or insect cells despite several attempts. However, when Flag-tagged
metabolically labeled with 32P-orthophosphate, we did not observe 32P incorpora
phosphoprotein that is a Fam20C substrate (see Figures 4A and 4D). We therefore
kinases.
(K) Protein immunoblotting of V5 and Flag immunoprecipitates from CM of U2
catalytically inactive D478A (20C D478A:Flag), or Fam20CKDEL (20C:Flag-KDEL).
See also Figure S2.
1622 Cell 161, 1619–1632, June 18, 2015 ª2015 Elsevier Inc.phopeptides (see Supplemental Experimental Procedures).
These results demonstrate that the majority of HepG2 secreted
phosphoproteins are Fam20C substrates. Importantly, several
HepG2 secreted phosphoproteins have been identified in human
serum (Zhou et al., 2009) and plasma (Carrascal et al., 2010)
phosphoproteomes (Tables 1 and S1).
Fam20C is also highly expressed in lactating mammary gland
and mineralized tissues; thus, we hypothesized that the land-
scape of secreted phosphoproteins might be distinct between
different cell types. To further explore the contribution of
Fam20C to the secretedphosphoproteome,wegenerated stable
Fam20C knockdown (KD) MDA-MB-231 (breast epithelial),
U2OS (osteoblast-like), andHepG2 (liver) cells using short hairpin
RNA (shRNA) and performed label-free phosphoprotein quantifi-
cation by means of mass spectrometry (MS) using conditioned
medium from control and Fam20C-deficient cells (Figures S5A–
S5E; Data S2). We identified more than 150 phosphopeptides
representing100 distinct secreted phosphoproteins that mark-
edly decreased in the Fam20C depleted cells (Tables 1 and 2).
Several Fam20C substrates were identified in multiple cell lines,
whereas most showed cell type specificity (Figure S5F).
Fam20C Directly Phosphorylates Serum, Plasma, and
CSF Phosphoproteins
Collectively, our secreted phosphoproteomic analyses of
HepG2, MDA-MB-231, and U2OS cells have established that
some 80% of secreted phosphoproteins are Fam20C sub-
strates. As mentioned, most phosphoproteins found in blood
and CSF are phosphorylated within the Fam20C S-x-E/pS motif
(Table S1). To determine if these proteins were genuine Fam20C
substrates and corroborate our MS results, we screened 25
candidate proteins for their ability to be directly phosphorylated
by Fam20C in vitro and/or in cells. Recombinant Fam20C effi-
ciently phosphorylated several of the candidate substrates2OS cells co-expressing V5-tagged OPN (OPN:V5) with either WT Fam20C
cosylation mutants. Extracts were analyzed for Fam20C-Flag (or mutants) and
-F.
om CM of 32P-orthophosphate-labeled U2OS cells expressing WT Fam20C
2OS cells co-expressing V5-tagged OPN (OPN:V5) with either WT Fam20C
d S372A). Extracts were analyzed for Fam20C-Flag (or mutants) and GAPDH.
osphatase (l-p’tase).
rylation of a positional scanning peptide library. The phosphorimage depicts
vidin-coated membrane. The positions are numbered relative to the central
vitro phosphorylation of the positional scanning peptide library by Fam20C.
C- and VLK-related kinases and Sgk196, expressed and purified from CM of
in the presence of [g-32P]ATP. The reaction products were analyzed by SDS-
40 in the presence of [g-32P]ATP. Incorporated radioactivity was quantified by
use we could not produce sufficient amounts of soluble recombinant protein in
Fam198Bwas coexpressed with V5-tagged Fetuin A (FetA) in mammalian cells
tion into V5-immunoprecipitates (data not shown). FetA is an S-x-E containing
conclude that Fam20C activity is unique among the known secretory pathway
OS cells co-expressing V5-tagged OPN (OPN:V5) with either WT (20C:Flag),
Extracts were analyzed for Fam20C-Flag (or mutants) and GAPDH.
Figure 3. Fam20C Generates the Majority of the HepG2 Extracellular Phosphoproteome
(A) Schematic representation of the workflow used in these studies.
(B) Volcano plot depicting the log2 of fold phosphorylation change (normalized to protein abundance) versus log10(p value) for phosphosites on secretory
pathway proteins. The phosphopeptides marked in red displayed a statistically significant decrease in Fam20C KO HepG2 cells (log2 fold change % 1;
log10(p value)R 1.3).
(C) Zoomed in view of the volcano plot in (B) highlighting the phosphopeptides that significantly decreased in Fam20C KO cells. OPN, osteopontin; IGFBP1,
insulin-like growth factor binding protein-1; FETUA, fetuin A; a-Feto, a-fetoprotein; ITIH2, Inter-alpha-trypsin inhibitor heavy chain H2; APOB, apolipoprotein B;
FGA, fibrinogen gamma chain; QSOX1, quiescin Q6 sulfhydryl oxidase-1; Lam, laminin; SCG1, secretogranin-1; TF, transferrin; APOL1, apolipoprotein L1; BMP4,
bone morphogenic protein-4; PCSK9, Proprotein convertase subtilisin/kexin type-9; APP, Ab precursor protein; HRC, histidine rich calcium binding protein; C3,
complement component C3; C4A, complement component.
See also Figure S3.in vitro in a time-dependent manner, whereas the inactive
Fam20C D478A mutant did not (Figures 4A and B). We also
analyzed V5 immunoprecipitates from conditioned medium
of mammalian cells co-expressing V5-tagged substrates with
either Flag-tagged Fam20C or the D478A mutant. Fam20C, but
not the inactive mutant, effectively phosphorylated each of the
secreted proteins as judged by their mobility during SDS-
PAGE (Figure 4C) or by incorporation of 32P into V5-immuno-
precipitates when the cells were metabolically labeled with 32P
orthophosphate (Figure 4D). Furthermore, we expressed
V5-tagged proteins in control and Fam20C KO U2OS cells
(Tagliabracci et al., 2014) that were metabolically labeled with
32P-orthophosphate and analyzed V5-immunoprecipitates from
conditioned medium (Figure 4E). The insulin-like growth factor
binding proteins (IGFBPs), proprotein convertase subtilisin/kexin
type-9 (PCSK9), and several neuropeptide hormone precursor
proteins, including proenkephalin (PENK) and the secretogra-
nins, were phosphorylated in control, but not in Fam20C KO
cells. Remarkably, Fam20C robustly phosphorylated every sub-
strate tested in vitro and in cells.Fam20C Has Broader Substrate Specificity Than
Previously Appreciated
Analysis of the amino acid motifs encompassing the peptide
phosphorylation sites in HepG2 cells, revealed that phosphoryla-
tion of secreted proteins on Ser residues was by far the most
common, followed by Thr and to a lesser extent Tyr (Figure S6A).
As expected, the majority of phosphosites that were signifi-
cantly decreased in Fam20C KO HepG2 cells corresponded to
the S-x-E/pS motif (Figure 5A). Surprisingly, we also identified
phosphosites that decreased in HepG2 Fam20C KO cells that
did not match the Fam20C consensus (Figure S6B). For
example, we identified several phosphosites within IGFBP1
that were decreased in Fam20C KO cells, yet did not conform
to the S-x-E motif (Figure 5B; Table 1). When expressed in
U2OS cells, V5-tagged IGFBP1 was phosphorylated by endog-
enous Fam20C and overexpressed Flag-tagged Fam20C
(Figures 5C and 5D). Therefore, to determine the sites of phos-
phorylation on IGFBP1 by Fam20C, we purified recombinant
IGFBP1 from insect cells, treated it with WT or D478A Fam20C
in vitro, and mapped the resulting phosphosites by MS (FiguresCell 161, 1619–1632, June 18, 2015 ª2015 Elsevier Inc. 1623
Table 1. Fam20C-Dependent Phosphosites in Secretory Pathway Proteins from HepG2 Cells
Function Protein Name (Gene Symbol) Phosphosites
Lipid binding and
homeostasis
apolipoprotein A2 (APOA2)* s54, s68
apolipoprotein B (APOB) s4048
apolipoprotein E (APOE)* s147
apolipoprotein L1 (APOL1)* s327, s330, s352, s355
apolipoprotein A-V (APOA5) T55
proprotein convertase subtilisin type 9 (PCSK9)* s47, s688
BPI fold-containing family B member 2 (BPIFB2) T52, s60
IGFBPs insulin-like growth factor binding protein 1 (IGFBP1)* s45, S156, T157, Y158, T193, s194, S199, s242
insulin-like growth factor binding protein 3 (IGFBP3)* s148
Neuropeptides secretogranin 1 (CHBG)* s130, s225, s367, s377, S380, Y401
cystatin family cystatin-C (CST3)* s43
kininogen-1 (KNG1) s332
alpha-2-HS-glycoprotein (P02765) (AHSG) S135, s138, s328, s330
alpha-2-HS-glycoprotein (C9JV77) (AHSG)* s139, T320, S326, s331
alpha-fetoprotein (AFP) S111, S115, s117, s344, s444, S445
Protease inhibitors and
metallo-proteases
alpha-1-anti-trypsin (SERPINA1) S38
protein Z-dependent protease inhibitor (SERPINA10) s56
antithrombin III (SERPINC1) T63, S68
heparin cofactor 2 (SERPIND1) S37
glypican 3 (GPC3) S352
inter-alpha-trypsin inhibitor H2 (ITIH2) s60, s466, s886
disintegrin and metalloprotease domain-containing
protein 10 (ADAM10)
T719
Calcium binding and
homeostasis
osteopontin (Isoform C) (SPP1)* T163, S164, s168, S188, S192, s197, Y198, S201,
s207, T210, S212, S216, s227, S231, s236, S240,
s243, s248, s253, s264, s276, s281, s283, S284
osteopontin (Isoform A) (SPP1) s63, T190, S191, s195, s224, s234, s228, s254, S258,
s263, s270, s275, s280, s291
osteopontin (Isoform 5) (SPP1) s26, s27
highly similar to osteopontin (B7Z351) (SPP1) s75, s76
reticulocalbin-1 (RCN1) s80
histidine-rich calcium binding protein (HRC)* T76, s119, s145, s358, s409, s431, s494, s567
nucleobindin-1 (NUCB1)* s86, s369, T148
stanniocalcin (STC2)* S250, s251, T254
calumenin, isoform 4 (CALU)* s77
glucosidase 2 subunit beta (PRKCSH) S24, s168
serum albumin (ALB) S29, s82, s91, T109
Adhesion cadherin-2 (CDH2) s96
amyloid beta A4 protein (APP) s385, s441
Extracellular matrix fibronectin, isoform 1 (FN1)* s2384
fibronectin, isoform 15 (FN1) s2475
laminin subunit beta-1 (LAMB1) s1502, s1520, s1690, s1706
laminin subunit beta-2 (LAMB2) s1532
laminin subunit gamma-1 (LAMC1) s1149
sulfhydryl oxidase 1 (QSOX1)* s426
bone morphogenic protein 4 (BMP4) s91
testican (SPOK2) s72
versican core protein (VCAN) s2116
matrillin-3 (MATN3) s441, T442
(Continued on next page)
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Table 1. Continued
Function Protein Name (Gene Symbol) Phosphosites
Complement system complement C3 (C3) s38, s70, s297, S303, S672,
S968, s1321, s1573
isoform 2 of complement C4-A (C4A) s918
Blood clotting coagulation factor V (F5) s859
fibrinogen alpha chain (FGA)* s45, s56, s364, S524, S560, S609
fibrinogen gamma chain (FGG)* s68
vitamin K-dependent protein C (PROC) s347
von Willebrand factor A domain-containing protein 1 (VWA1) S74, S80, Y83, s93
Signaling and protein
transport
trans-Golgi network integral membrane protein 2 (TGOLN2)* s71, S221, s298, T302, s351
neurosecretory protein VGF (VGF) s420, T424
melanoma inhibitory activity protein (MIA3) s226, s229, S1906
endoplasmin (HSP90B1) S306
Metal binding serotransferrin (TF) s389, S685
ceruloplasmin (CP) S722
Other protein disulfide isomerase A1 (PDIA1) S208
protein disulfide isomerase A6 (PDIA6) s357
plasma alpha-L-fucosidase (FUCA2) S301
DNAJ homolog subfamily C member 3 (DNAJC3) s274
protein notum homolog (NOTUM) S81
alpha-1,3-mannosyl-glycoprotein 4-beta-N-
acetylglucosaminyltransferase A (MGAT4A)
s474
syndecan-2 (SDC2) S115
Phosphoserines within a Fam20C consensus motif (pS-x-E/pS) are indicated by a lower case ‘‘s.’’ Non pS-x-E/pS sites are indicated by a capital letter
(S, T, or Y). *Indicates if the protein was confirmed to be a Fam20C substrate in either cell-based or in vitro kinase assays.
See also Figure S4 and Table S1.5E, 5F, S6E, and S6F). Wild-type Fam20C, but not the D478A
mutant, phosphorylated several sites on IGFBP1 that did not
conform to the S-x-E/pS motif, including Ser45, Thr193, and
Ser199. Fam20C was unable, however, to phosphorylate these
residues when synthetic peptides were used as the substrates.
These results suggest that Fam20C may require additional fac-
tors beyond the primary substrate sequence seen when small
peptides are used as substrates. Furthermore, after examining
the phosphosites in HepG2, MDA-MB-231, and U2OS cells we
did not observe a significant correlation between relative expres-
sion of Fam20C and the proportion of substrates that were phos-
phorylated on residues that did not conform to the S-x-E/pS
motif.
Our findings are consistent with previous work using pep-
tides derived from proline-rich phosphoprotein 1 (PRP1), which
demonstrated that the Golgi casein kinase, later identified as
Fam20C, could phosphorylate a S-x-Q-x-x-D-E-E motif (Fig-
ure 5G) (Brunati et al., 2000). This activity required the Q at
the +2 position and the three acidic residues at the +5, +6,
and +7 positions. Fam20C also phosphorylated this Ser in vitro
using a synthetic peptide as substrate (Figures 5H and 5I) and
in cells when PRP1was expressed as a V5-tagged fusion protein
(Figures 5J and 5K). As anticipated, Fam20C required the Q
at the n+2 position and acidic residues at the +5, +6, and +7
positions. Analysis of the C. elegans Fam20C crystal structure
revealed several conserved basic residues that were proposed
to interact with these downstream acidic residues (Xiao et al.,2013). Collectively, these results demonstrate that Fam20C
can recognize amino acid sequences in addition to the
canonical S-x-E/pS motif and suggest that Fam20C-dependent
phosphorylation is more extensive than indicated solely by those
substrates phosphorylated within the canonical recognition
sequence.
GO Term Analysis of Fam20C Substrates Reveals an
Unexpected Role for Secreted Protein Phosphorylation
in Cell Adhesion, Migration, and Invasion
Human FAM20C mutations cause Raine syndrome, an osteo-
sclerotic bone dysplasia (Raine et al., 1989; Simpson et al.,
2007). The defects in bone formation in Raine patients under-
score the importance of Fam20C-dependent phosphorylation
of secretedproteins, such as theSIBLINGs, for the process of tis-
sue mineralization. However, Fam20C is likely to have additional
physiological functions because it is ubiquitously expressed,
conserved in organisms that do not have mineralized tissues
(Nalbant et al., 2005; Tagliabracci et al., 2013b; Wang et al.,
2012; Xiao et al., 2013), and most Fam20C substrates identified
in this work have no apparent link to biomineralization. Gene
ontology (GO) term analysis using the DAVID server (Huang
et al., 2009) showed that biological processes, such as wound
healing, lipid homeostasis, endopeptidase inhibitor activity, cell
adhesion, and cell migration, were enriched in the Fam20C-
regulated gene set (Figure 6A; Data S3). To establish whether
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Table 2. Fam20C-Dependent Phosphosites in Secretory Pathway Proteins from MDA-MB-231 and U2OS Cells
Function Protein Name (Gene Symbol) Phosphosites
MDA-MB-231 Cells
Lipid binding and homeostasis proprotein convertase subtilisin/kexin type 9 (PCSK9)* s688
patatin-like phospholipase domain-containing protein 2 (PNPLA2) S404
IGFBPs insulin-like growth factor-binding protein 3 (IGFBP3)* s201
insulin-like growth factor-binding protein 4 (IGFBP4)* S255
insulin-like growth factor-binding protein 7 (IGFBP7)* s239
insulin-like growth factor-binding protein 10 (CYR61) S188
Cystatins cystatin-C (CST3)* S43
Protease inhibitors and proteases metalloproteinase inhibitor 1 (TIMP1) S178
amyloid-like protein2 (APLP2) s590
serine protease 23 (PRSS23) S109
Calcium binding and homeostasis reticulocalbin-1 (RCN1) s80
follistatin-related protein 1 (FSTL1) s165
follistatin-related protein 3 (FSTL3) s255
nucleobindin-1 (NUCB1)* s369
calumenin (CALU)* s77
wolframin (WFS1) T30, s32
glucosidase 2 subunit beta (PRKCSH) s168
Adhesion lactadherin (MFGE8) s42
isoform 3 of Mesothelin (MSLN) s200
Extracellular matrix isoform 15 of Fibronectin (FN1)* s2475
isoform 3 of Latent-transforming growth factor beta-binding protein 1 (LTBP1) s1035
bone morphogenic protein 4 (BMP4) s91
galectin-1 (LGALS1) S30
fibrillin-1 (FBN1) s2702
tenascin (TNC) s72
Signaling and ion transport growth arrest-specific protein 6 (GAS6) s71
interleukin-6 (IL6)* s81
macrophage colony stimulating factor 1 (CSF1) T266
chordin-like 1 (CHRDL1) s186
melanotransferrin (MFI2) S462
anoctamin-8 (ANO8) S801
Other cytoskeleton-associated protein 4 (CKAP4) s232
transmembrane protein 132A (TMEM132A) s530
fam176A (protein eva-1 homolog A) (EVA1A) s114
Golgi membrane protein (GOLM1) s309
kinectin (KTN1) S75
isoform 2 of matrix-remodeling-associated protein 8 (MXRA8) s228
U2OS cells
IGFBPs insulin-like growth factor-binding protein 5 (IGFBP5)* s116
insulin-like growth factor-binding protein 7 (IGFBP7)* s239
Protease membrane-bound transcription factor site-1 protease (MBTPS1) S168
Adhesion cadherin-2 (CDH2) s135
isoform 3 of Mesothelin (MSLN) s200
Calcium binding follistatin-related protein 3 (FSTL3) s255
Other shisa-5 (SHISA5) s115
Phosphoserines within a Fam20C consensus motif (pS-x-E/pS) are indicated by a lower case ‘‘s.’’ Non pS-x-E/pS sites are indicated by a capital
letter (S, T, or Y). *Indicates if the protein was confirmed to be a Fam20C substrate in either cell-based or in vitro kinase assays. See also Figure S5
and Data S2.
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Figure 4. Fam20C Directly Phosphorylates Serum, Plasma, and CSF Proteins
(A) Time-dependent incorporation of 32P from [g-32P]ATP into IGFBP3, PCSK9, Fetuin A (FetA), IGFBP5, fibronectin, and fibrinogen by Fam20C, or the D478A
mutant. Reaction products were separated by SDS-PAGE, visualized by Coomassie staining, and radioactivity was detected by autoradiography.
(B) Time-dependent incorporation of 32P from [g-32P]ATP into MBP-tagged calumenin (MBP-Calu), interleukin-6 (MBP-IL-6), stanniocalcin 2 (MBP-STC2), and
nucleobindin 1 (MBP-NucB1). MBP was also analyzed as a control for the indicated time point. Reaction products were analyzed as in (A).
(C) Protein immunoblotting of V5-immunoprecipitates from conditioned medium (CM) of U2OS or HEK293T cells co-expressing V5-tagged IGFBP3, IGFBP4,
IGFBP5, IGFBP7, proenkephalin (PENK), secretogranin 1 (SCG1), SCG2, secreted phosphoprotein 2 (Spp2), stanniocalcin 2 (STC2), secretogranin 3 (SCG3),
cystatin C (CysC), ApoL1, SparcL1, trans Golgi network protein 2 (TGOLN2), NucB1 and IL-6 with WT (20C:Flag), or Fam20C-D478A (20C DA:Flag). V5-
immunoprecipitates were treated with l-phosphatase (l-p’tase).
(D) Protein immunoblotting and autoradiography of V5-immunoprecipitates from CM of 32P-orthophosphate-labeled U2OS cells co-expressing V5-tagged
apolipoprotein A1 (ApoA1), ApoE, FetA, quiescin Q6 sulfhydryl oxidase 1 (QSOX1), PCSK9, ApoA2, and Calu with 20C:Flag or 20C DA:Flag.
(E) Protein immunoblotting and autoradiography of V5-immunoprecipitates from CM of 32P-orthophosphate-labeled control and Fam20C KO U2OS cells
expressing V5-tagged IGFBP3, IGFBP5, SCG1, histidine rich calcium binding protein (HRC), PCSK9, PENK, SCG2, and SCG3. Protein immunoblotting of
V5-immunoprecipitates from CM (top) and autoradiography depicting 32P incorporation into the V5-tagged substrates (middle). Fam20C protein levels in CM
(bottom).
See also Table S1.promotes cell adhesion and migration, the FAM20C gene
was disrupted by means of CRISPR/Cas9 genome editing in
MDA-MB-231 cells, a highly invasive breast cancer cell line (Fig-
ure S7). We initially analyzed the ability of Fam20C KO cells to
adhere to culture dishes by monitoring cell detachment. Cells
depleted of Fam20C had altered adhesive properties as judged
by their resistance to detach in the presence of phosphate
buffered EDTA (Figure 6B). We then monitored cell migration in
scratch wound-healing experiments and demonstrated that
Fam20C KO cells were also severely impaired in their ability to
migratewhencompared tocontrol cells (Figure 6C). Furthermore,
depletion of Fam20C largely blocked the ability of these cells to
migrate in transwell chemotaxis and 2DMatrigel invasion assays(Figures 6D and 6E). These results support that Fam20C-depen-
dent phosphorylation of secreted proteins is necessary for the
proper adhesion, migration, and invasion of breast cancer cells.
To test whether phosphoproteins in conditioned medium from
WT cells could rescue themigration defects in Fam20C-deficient
cells, we performed a media swap experiment. When Fam20C
KO cells were cultured in serum-free conditioned medium from
WT cells, the Fam20CKOcell migration phenotypewas rescued;
demonstrating that Fam20C-dependent phosphorylation of
soluble, secreted proteins promotes cell migration (Figure 6F).
To identify secreted phosphoproteins whose phosphorylation
can stimulate MDA-MB-231 breast cancer cell migration, we
developed a cell-based assay to screen candidate Fam20CCell 161, 1619–1632, June 18, 2015 ª2015 Elsevier Inc. 1627
Figure 5. Fam20C Exhibits Broader Substrate Specificity Than Previously Appreciated
(A) Weblogo depicting the phosphopeptides that displayed a significant reduction in Fam20C KO HepG2 cells. The number (n) of phosphopeptides analyzed to
generate the Weblogo is shown in the inset.
(B) Schematic representation of IGFBP1 depicting residues (red) whose phosphorylation decreased in Fam20C KO HepG2 cells (SP, signal peptide; TY,
Thyroglobulin-1).
(C) Control and Fam20C KOU2OS cells were metabolically labeled with 32P-orthophosphate and transfected with V5-tagged IGFBP1. Protein immunoblotting of
V5 immunoprecipitates from conditioned medium (CM) (upper) and autoradiography depicting 32P incorporation into the V5-tagged IGFBP1 (middle). Fam20C
protein levels in CM are also shown (lower).
(D) Protein immunoblotting of V5 immunoprecipitates from CM of U2OS cells co-expressing V5-tagged IGFBP1 with either WT (20C:Flag) or catalytically inactive
D478A (20C DA:Flag). V5-immunoprecipitates were treated with l-phosphatase (l-p’tase).
(E) Time-dependent incorporation of 32P from [g-32P]ATP into IGFBP1 by recombinant Fam20C or the D478Amutant (DA). Reaction products were separated by
SDS-PAGE, visualized by Coomassie staining, and radioactivity was detected by autoradiography.
(F) Representative MS/MS spectrum of a diphosphopeptide identifying phosphorylation of Thr193 and Ser194 on human IGFBP1 after Fam20C treatment. The
precursor ion with m/z 669.74 eluted at 5.32 min.
(G) Schematic representation of PRP1 depicting the two phosphoserines (site 8, green; site 22, red).
(H) Recombinant Fam20C was incubated with peptides representing the PRP1 site 8 and 22 Ser residues in the presence of [g-32P]ATP and incorporated
radioactivity was quantified by means of scintillation counting. The b28-40 peptide was also analyzed.
(legend continued on next page)
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substrates for their ability to rescue the cell migration defects in
Fam20C KO MDA-MB-231 cells (Figure 6G). We cultured
Fam20C KO MDA-MB-231 cells in serum-free conditioned me-
dium collected from U2OS cells that were coexpressing WT or
D478A Fam20C with some 20-candidate V5-tagged substrates
and performed scratch wound-healing experiments. Most
Fam20C substrates had little effect on cell migration in the
Fam20C KO MDA-MB-231 cells. Furthermore, the presence of
WT or inactive Fam20C in the conditioned medium did not affect
cell migration. We did, however, observe a significant increase in
cell migration when the Fam20C KO cells were cultured in me-
dium containing phosphorylated, but not unphosphorylated,
IGFBP7 (Figure 6H). As their name implies, the IGFBP’s bind
IGF-1; however, we did not detect IGF-1 protein in conditioned
medium of MDA-MB-231 or U2OS cells (Data S2). Therefore,
we conclude that phosphorylated IGFBP7 promotes cell migra-
tion in an IGF-1 independent manner. Indeed, there are several
reports describing IGF-1-independent functions for the IGFBP’s
(Baxter, 2014). Collectively, these results suggest that Fam20C-
dependent phosphorylation of IGFBP7 contributes to breast
cancer cell migration.
DISCUSSION
Although numerous secreted proteins and peptide hormones are
phosphorylated, the molecular identities of the kinases respon-
sible for these modifications have only recently been identified
(Bordoli et al., 2014; Ishikawa et al., 2008; Tagliabracci et al.,
2012, 2013a). Our knowledge about these enzymes is in its in-
fancy and extracellular protein phosphorylation will likely emerge
as a fundamental mechanism that regulates many physiological
processes. Nearly 60 years of protein phosphorylation research
have uncovered many functions for intracellular phosphoryla-
tion, and there is no reason to believe these mechanisms will
be any different for protein phosphorylation that takes place in
the ER/Golgi lumen or outside the cell.
David GO term analysis showed that biological processes,
including wound healing, lipid homeostasis, endopeptidase in-
hibitor activity, and cell adhesion and migration, were enriched
in the Fam20C-regulated gene set (Figure 6A; Data S3). Substan-
tiating these observations, Fam20C MDA-MB-231 KO cells did
not detach as readily as WT cells and displayed a significant
reduction in their ability to migrate in scratch-wound healing
and chemotaxis migration assays. Furthermore, Fam20C ap-
pears to be necessary for these cells to invade Matrigel-coated
transwells, a process largely dependent on extracellular prote-
ase activity. Numerous Fam20C substrates have been impli-
cated in tumor growth and metastasis, including the IGFBPs
(Baxter, 2014), OPN (Bellahce`ne et al., 2008), several extracel-
lular proteases, and the serine protease inhibitors (Serpins) (Va-(I) A peptide representing the PRP1 site 22 Ser was synthesized and used to furth
was monitored by autoradiography.
(J) Control and Fam20C KOU2OS cells weremetabolically labeled with 32P-orthop
immunoprecipitates from CM (upper) and autoradiography depicting 32P incorpo
(K) Protein immunoblotting and autoradiography of V5-immunoprecipitates from C
or the site 8 and 22 Ala mutants with either WT (20C:Flag) or Fam20C-D478A (20
See also Figure S6.liente et al., 2014). Therefore, loss of phosphorylation of multiple
Fam20C substrates could contribute to the cell motility defects in
Fam20C-deficient breast cancer cells. We discovered that phos-
phorylated IGFBP7 was able to largely rescue the cell migration
defects in MDA-MB-231 cells that were depleted of Fam20C
(Figure 6H). The molecular mechanism(s) by which Fam20C-
dependent phosphorylation of IGFBP7 potentiates cell migration
are currently unknown. However, both the IGFBP7 and the
FAM20C gene are amplified or overexpressed in human cancers
(Bieche et al., 2004; Cerami et al., 2012; Gao et al., 2013;
Georges et al., 2011; Jiang et al., 2008).
Interestingly, a recent analysis of the phosphoprotein secre-
tome of tumor cells and patient plasma has uncovered candi-
dates for breast cancer biomarkers, including IGFBP3, IGFBP5,
OPN, follistatin-like 3, stanniocalcin-2, and cystatin C. (Za-
wadzka et al., 2014). Virtually every phosphopeptide identified
was phosphorylatedwithin the Fam20C consensus S-x-E recog-
nition motif. Indeed, we also identified all of these proteins as
Fam20C substrates in this study. Thus, inhibition of Fam20C
may be a viable therapeutic strategy to prevent tumor cell pro-
gression and metastasis.
Many Fam20C substrates have been implicated in other
human diseases, and missense mutations within or surrounding
Fam20C-dependent S-x-E phosphorylation sites have been
identified. For example, we identified Ser47 on PCSK9, a prote-
ase implicated in low-density lipoprotein cholesterolmetabolism,
as a Fam20C-regulated phosphosite (Table 1). Amissensemuta-
tion of a potential protease cleavage site in PCSK9 adjacent to
Ser47 (Arg46Leu) leads to low plasma levels of LDL cholesterol
(Dewpura et al., 2008; Kotowski et al., 2006). This is notable
because we have previously shown that Fam20C-dependent
phosphorylation of FGF23 regulates its proteolytic cleavage
and has important implications in phosphate homeostasis
(Tagliabracci et al., 2014).
We have also identified Ser91 on bone morphogenic protein-4
(BMP4) as a Fam20C-dependent phosphosite (Tables 1 and 2).
BMP4 is a member of the transforming growth factor-b super-
family and controls cellular proliferation and differentiation. In
humans, missense mutations of BMP4 on Ser91 and Glu93
cause renal hypodysplasia and anophthalmia-micropthalmia
(Bakrania et al., 2008; Weber et al., 2008). Both of these sites
fall within the 91S-G-E93 motif, and the mutations would be pre-
dicted to disrupt Fam20C-dependent phosphorylation. This is
reminiscent of what has been observed with the enamel matrix
protein enamelin, where loss of Fam20C-dependent phosphor-
ylation of a 216S-x-E218 motif, caused by a Ser216Leu mutation,
is sufficient to cause amelogenesis imperfecta (Chan et al.,
2010).
The results of this study expand our understanding of the
rapidly developing field of extracellular protein phosphorylationer assess the specificity determinants for Fam20C. Incorporation of phosphate
hosphate and transfected with V5-tagged PRP1. Protein immunoblotting of V5
ration into PRP1 (middle). Fam20C protein levels in CM are also shown (lower).
M of 32P-orthophosphate-labeled U2OS cells co-expressing V5-tagged PRP1
C DA:Flag).
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Figure 6. GO Term Analysis of Fam20C Substrates Reveals an Unexpected Role for Secreted Protein Phosphorylation in Cell Adhesion,
Migration, and Invasion
(A) DAVID GO term analysis using the HepG2 Fam20C-regulated gene set. The graph represents the statistically significant enriched gene clusters with the
number of genes in each cluster indicated beside the bars.
(B) Bar graph depicting cell detachment in a cell adhesion assay usingWT and Fam20CKOMDA-MB-231 cells. Data report detached cells (%of total) after 10min
treatment with PBS-buffered EDTA and represent the mean (±SD) of ten replicates in two independent experiments (***p% 0.0001 versus WT).
(C) Bar graph depicting cell migration (area of wound covered) in a scratch wound-healing assay using WT and Fam20C KO MDA-MB-231 cells. Data were
acquired 7 and 20 hr after the scratch and represents the mean (±SD) of three independent experiments (***p% 0.0001 versus WT).
(D) Bar graph depicting cell migration/chemotaxis in a transwell migration assay usingWT and Fam20C KOMDA-MB-231 cells. Mediumwith 10% FBSwas used
as a chemoattractant. Data were acquired 24 hr after seeding in upper chamber of 8 mm pore size transwells and is expressed as average number of cells/field
(±SD) from three independent experiments (*p < 0.05 versus WT).
(E) Bar graph depicting cell migration/invasion in aMatrigel transwell migration assay using control and Fam20CKOMDA-MB-231 cells. Data were acquired 24 hr
after seeding in upper chamber of 8 mm pore size transwells. Cells that invaded the Matrigel were quantified based on DNA content using CyQuant dye and
normalized to WT. Data represent mean (±SD) from three independent experiments (***p% 0.0001 versus WT).
(F) Bar graph depicting cell migration (area of wound covered) in a scratch wound-healing assay using WT and Fam20C KO MDA-MB-231 cells. Cells were
incubated in SFM or conditioned medium (CM) from Fam20CWT or KOMDA-MB-231 cells as indicated during wound-healing. Data were acquired 6 hr after the
scratch and depicts mean (±SD) from a representative experiment performed in triplicate (***p = 0.0002 versus WT, **p = 0.0025 versus KO).
(G) Workflow used to screen candidate Fam20C substrates in the scratch-wound healing assay shown in (H).
(H) Bar graph depicting cell migration (area of wound covered) in a scratch wound-healing assay using WT and Fam20C KO MDA-MB-231 cells. Cells were
incubated in SFM or CM from U2OS cells that were transfected with either vector (Control), IGFBP7-V5 + WT Fam20C (pIGFBP7), or IGFBP7-V5 + D478A
Fam20C (IGFBP7) as indicated during the wound-healing. Data were acquired 6 hr after the scratch and shows mean (±SD) of a representative experiment
performed in triplicate (*p = 0.0146 versus IGFBP7, **p < 0.0001, ***p = 0.0098 versus KO). An immunoblot of V5-immunoprecipitates from the CM of U2OS cells
used in the rescue experiments is shown in the inset.
See also Figure S7.by kinases in the secretory pathway and the extracellular
space. We identified over 100 secreted proteins as Fam20C
substrates and have established Fam20C as the major secretory1630 Cell 161, 1619–1632, June 18, 2015 ª2015 Elsevier Inc.pathway protein kinase. Our work opens new areas of research
on extracellular protein phosphorylation in human biology and
disease.
EXPERIMENTAL PROCEDURES
Additional procedures can be found in the Supplemental Experimental
Procedures.
Kinase Assays
In vitro kinase assays using protein and peptide substrates were performed as
described (Tagliabracci et al., 2012). PRP1 site 22 peptides were synthesized
on derivatized cellulose membranes and used in kinase assays as described in
Tagliabracci et al. (2012).
Arrayed Positional Scanning Peptide Library
A Ser/Thr peptide library set consisting of 198 biotinylated substrates was pur-
chased from Anaspec and assayed as described (Chen and Turk, 2010).
Detachment, Scratch-Wound, and Transwell Migration Assays
The detachment assay was performed as described with minor modifications
(Gagnoux-Palacios et al., 2001) and quantified using the fluorescent CyQuant
DNA-binding dye (Life Technologies). The scratch wound-healing assay was
performed as previously described (O’Neill et al., 2011). WT and Fam20C KO
MDA-MB-231 cells were grown to confluence, the monolayer was scratched
with a pipet tip, and the cells were imaged at 0 hr and various time points
post-scratch. Theareamigratedwasquantified.For the IGFBP7mediaswapex-
periments,U2OScellswere transfectedwith either vector, IGFBP7-V5+D478A-
Fam20C, or IGFBP7-V5 +WT-Fam20C, followed by incubation for 30 hr in SFM
to generate conditioned media that was applied to MDA-MB-231 cells post-
scratch. The transwell chemotaxis migration assay was performed using 8-mm
pore size transwells following standard protocols. The bottom chamber con-
tained normal growth media (DMEM with 10% FBS) as a chemoattractant. WT
or Fam20C KO MDA-MB-231 cells were seeded into the upper chamber
(20,000 cells/insert) in SFM. After 24 hr of culture, cells that migrated through
the poreswere imaged and quantified.Matrigel invasion assayswere performed
similarly as above and as previously described (Sodek et al., 2008); transwell in-
serts were coated with Matrigel (BD Biosciences) before seeding cells.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, one table, and three data files and can be found with this article
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